Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum MEDRELEAF CORP T.LEAF

Healthcare Drug Manufacturers - Specialty & Generic
"MedReleaf Corp is engaged in the production and sale of cannabis for medical purposes as regulated by the ACMPR, pursuant to its Licences and, in particular, its Markham Commercial Licence."

TSX:LEAF - Post Discussion

MEDRELEAF CORP > ACB $8.47*3.575 = $30.28 LEAF
View:
Post by MartialArts on May 23, 2018 8:28pm

ACB $8.47*3.575 = $30.28 LEAF

Enjoy the $5 discount on LEAF while it lasts. The same thing happened with CMED until CMED caught up to the linked prices via the ratio.


With Canopy listing on the NYSE tomorrow, the sector will get a lot of new investors.

ACB will follow suit shortly.
Comment by longonMJ on May 24, 2018 2:15am
If I remember correctly, I believe the arbitrage discount on CMED lasted right through until just the week before the actual takeover.  So, we probably still have a long ways to go before this discount starts to dwindle back down. I don't believe we even have a tentative date for this proposed takeover yet, as they still have to go through the shareholder voting first. Not sure about ...more  
Comment by Oldweed on May 28, 2018 1:44pm
Would you recommend buying LEAF now to aquire ACB or wait till the shareholder vote?
Comment by jschrode42 on May 28, 2018 8:57pm
Deal risk looks pretty low on this one. If you're going to get in anyway there's probably no advantage to waiting (in my opinion). 
MEDRELEAF CORP
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities